Diagnostic utility of echocardiography in evaluation of syncope  by Redberg, R.F. et al.
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me charge bu?Jlmg mode4 afmbu?eS me fQw &?f~bnllaInu, Ikfeshokl (RF?) Ol 
the bvhastc wauelomr lo lhq fall of ewess charge @ the. 2nd phase 
rnk5 nwckl pfec@cIs @at he tmnsm@nbtane potentfar change (Al/m) tof the 
best Mkwiec wwWms IS QepdafusIw durtnq fhe 1st phase kMowed by 
rc?MnotVmduringR\emd~~r~~~~~~~~~~~lst 
phase To test Ihis pte@cIhm, _\Vm dutmg a bqrhas% shock known m have a 
low OFT was recorded in 4 gwnea mg paptaary rm@es by a double-barrel 
B WIN& &minated the shy& amtact Foffowmg IO Si sf~muh i 
sfl ma brpoasic trurwated ex)mnential 52 shock (6 ms bme constant) of 4-6 
V/cm was given dunng Ihe pfaIeau of Ihe fasl Sl ac~mn pmtial Far sticks 
that depotad the memb+ane pdentlal ckmng Ihe 1st phase, 3Vml was 
the vcdlage btffefence behvevn Vm just before the shock and the maxImum 
Vm ctunng the 1st phase. 1Vm2 was tha voltage diflerence between Vm lust 
betore Ihe shuck and me mnnmum JVm dtmng me 2nd phase. 
Avmh 
f?esu/rs AVml was 51 : lSmVand.\Vm2was44 : 23mV(p. 005 
us. 0 mV) Thus. because at the nonl~oear rect~ly~ng propemes 01 lhe cell 
membrane. hyperpotanzason dunng the 2nd phase is almoal as large a$ 
depolaruation dunng ihe 1st phase (Fig). These findings do not ~ppcn the 
charge burping model wh!ch predicts lhat _\VmZ should be near zero for an 
eflrwnous biphasic waveform. 
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Prevalence-mctdence bias can ltmlt the generabzab!llty of cllnlcal mats It 
consists in the distortjon 01 the cknically relevant cohort of Incident cases by 
the preferential inclusfon of ‘avatlable’ prevalem cases Hnth better prognosis. 
AVID was a multicenter randomized trial companng ICDs vs. antianhythmlc 
drugs in 1.016 Sun/~vors 01 cardiac arrest or hemodynamlcelly compiwnrslry 
VT. In cknrcal praclice, the defimtive treatmenl 01 these pts is generally 
decided during the frrst week after the event. but the AVID enrollment window 
of up to 6 months opened the possibility for prevalence-Incidence bias. 
We compared the baseline characteristics and outcume of AVID ‘mcident” 
pts randomized within the first week (NC: n = 576) and ‘prevalent’ pts 
randomized 18 days alter the index event (PREV: n = 440). PREV pIS were 
more likely to have a prior history of VF (7% vs. 20b; p < 0.001). to undergo 
CABG (11% VS. 6%; p = O.QOl) or PTCA (596 VS. 2%: p = 0.009) after the 
index episode, to belong to a minority (17% vs. 10%: p = 0.002) and to be 
treated at a VA hcspital(l3% vs. 8%; p = 0.01). and IeSS likely to have prrvate 
insurance (33% vs. 41%; p = 0.01) or prior MI (63% vs. 70%; p = 0.001). 
Despite these differences, 2.year swvival was not significantly different (61 i 
4% in INC vs. 76 * 5% in PREV: p = 0.26: log-rank test). even altar adlusting 
for baseline variables and discharge treatment. 
Conc/us~ons In AVID, Iho time from the lndox ev%ni lo raodemrratw e- 
pended pamally an clmtcal. damographho and msttltuttonal factors However 
pts randomlxed later after the mcfsx event did nal represent a lowor.rt& group 
‘!arknce et Manophauk Upper Llmlt Qt 
‘&lnernblllty Meaiu~lo fn Ntknlm 
UndergoIng Acthrr Can hnpkntabk CadW 
tWlbdlater hnplent8tbn 
A#@!#& We eoughr IO determine Ihe= magmtude of v6nallCe In ULV 
In 63 MHIgecullW PI ur&?rgotng ICD Itnplanlahon. We mearmrad ULV as 
the strengm 41 OI above whfch vanlnculat IibnllatKHI 18 not induced when a 
sttlmuluue IS dekvered 31Q ma affer m fJ beat venmcular pacmg drive Iram et 
400 ms. We meaoured defibnllatron lhreahold (DFT) in pt wlM an aclrve can 
devrca lrsmg a bphasrc wave form and Ihe bmary 5earch maIho@ 
&suns: The mean age was 63 + 12 years. and mean e+zflon fractron 
was 35 * 15%. The mean ULV was 8.7 f 5 4 @es (J) and fhe mean DFT 
was IO.0 2 4.9.l fech pI had 4.5 * 0.6 ULV measurements. Monophas~ 
ULV coneta@d poorty wl(h btphasie OFT (R = 0 27. p = 0 04). Change m 
ULV was calculalad from Iha IlrsI to second $+?cond IO I!xrd. fhlrd to foufih 
andhrst~llirstmeasurenrenhi.Themean~o~pt~hm,cha~w~300~~. 
wxth a change of l-3 J was 57%. and with a change of 3 J was 13%. ?%a 
mtracfasa conelatmn co@rcrenI of reSab#lny was 0.21 which m&oates a large 
vanance m Ihe measurement ol ULV 
Summary: Monophasrc ULV% ba not wrrelate well wnth MPhaSlc actwa 
can DOTS. High DFT’s were predicted ty hrgh ULv’5. but a Comldereble 
vanatwn m [he acute measuremen of ULV ex1s(6- l?xse hn6fngs ha@ 
Importam rmpkcatlons tar research usln~ ULV 
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~1048-113 ] Prospective Evalustion ot the Utility qt 
Echocardiography in the Evaluation of Patients 
with SyncQpe 
AG Olal!doye. A Paszczuh L.V. Cad. R Powers, C. Chen, L.Q. Gtllam 
lfar~ibrd Hosprfal. ffartlbrd. cl: USA 
While echocardrograpby (2DE) 1s often uoed IO evaluete patrents (pIs) ~nth 
syncope~I$~lltlyrnIhtsarearsnot welldehned. Indeed. Ifrecurrent ACC/AAHA 
Gurdelines for the Clinrcal Applrcatton of EchocardIography nolo a ‘strung 
need”foralargepmspectlve study In this area. To eddress thr~ mue. 259 
c~nSecuttve ptS (age 67 f 16 yr~) admitted 10 Il?e emergency deparhrrent 
wtth syncope were evaluated wtth ZDE. 2DE findings ware mvh?wed In lhe 
context of dintcal data mcludmg history. phySical examtnatkm. EKG. and. 
when avallable. Hotter and/or electmphVs~&g~c evaluation. The diagnostic 
yield 01 2DE was categorized as. I . ldentlfled abnarmallty fell to be sole 
cause 01 syncope. II _ @?nt#ted abnormaltty cantnbuhng 10 syncope in pts 
with co-extsteot anhytma. Ill -demonstrated no perlInen abnOmX3llty 
Results: The dragnostlc yreld was I . 78?0. II - 12%. 111 - 80.2% ZDE 
diagnoses m category I mcluded severe aortlc steno% IHSS. severe pul- 
monary hypertension. and acute pulmonary embotll. CategorY II pattents 
mcluded those wrth mbld to moderate AS. acute my0cafdlal InferchoR moder- 
ate to targs pemardtel effuston. end prevtously umuspectad kn vmbmki~ 
dysfunct!on m whom ventncular or atnal anhythmla was demonStfZited. 
Concrus~ons. In pts with syncope. 2DE pmvldes usetul dlagnostlc mIOr. 
mation In 19 6% In 7 6%. thts lntormatton 8s diagnostic These data SutJPJfl 
a role for 2DE In pts wxth syncope. However m pts In whom a non*ardzK 
cause of syncope is apparent and there IS no clmrcal SuspinOn Of heart 
disease. the test may be inappmpnate. 
I 1048 114 Diagnostic Utility of Echocardiography in Evaluation of Syncope 
RF. Redberg. R. Ferguson. J.P. Miller. L.W. Lissin. MC Dam. Unrvenityof 
California San Frannsco. USA 
gency room VISITS. nnnually. Echocardiography la commonly lncludad In tha 
work-up ol this papulallon. Tho purpose 01 this study Is to dotermlno lho 
dfagnostlo ylold 01 echo In tho ovaluntlon of syncopo. 
Melhods: Modlcsl racorde of 117 consoculivo pntlents wllh nn ndmlselon 
diagnosta of syncopa (ICD.9 799 2) wora ravlowod. Flfloen war0 oxcludad 
dun to nlkIdlsfYIOtIQs. 
Resulfx: Tha mean aga was 69 t 14 yams (rang0 21-101). ~fx~flvo 
percent were male. Tha two most Iroquent dlagnaatlc tnata parlormod worn 
EGG (94%) and echo (97%). Abnarmnlltles were observed In 60% of achoaa 
nnd !if!.% al ECQs. Abnormal echo llndlngs lnoludsd 12 canes ol aortlc at(lno~ 
RI@, BB ORATE of vnlvulnr Inaufflclancy and ona aas@ 01 ldlopalhlc hypaflrophlo 
nubnorlla rtanoals. Thlrt~~hma psmant al patknta damonetratad nt la~at 
modarata rsdufitlon In lalt vontrlaulnr Iunfitlon. Rnglonnl wall motlon nbnor. 
malIla worn notad In 19 pntkmts, RP?h Involving the Inlarlar wnll. The mont 
common atlologles lor ayncops waro finrdlna nrrhylhmlns (3996) nnd mllax 
mrrdlatad QRURQ~I (199h). 
Concfualen: Thoaa dntn sugffaat a hlgh prnvnlancn ol nbnormnl acha 
tmdlnga in pntlnnts pmaantlna with syneopo, most commonly vnlvular fib. 
normnlltl@x andlor myacnrdlnl dyrlunctlan. The pravnlanoe al t.V dyalunctton 
and fegtentll wnll motion abnnnalltle% espoofnlly In tha Inlatlar wall rntaa 
tha queatlan PI tmnalant AV nnda lachnmln (with sub8oquant Rrrhythmfn) AR 
R aaua~ ol ayncopa. Thl8 flndlng wnrrants lurthar Invoatlgatlon In n pmapoc. 
tlva tnahten. Althauflh thorn Is n high pmvnlonaa al nbnonnl ache lmdinga 
In older patlanta pmaontln9 with nyncope. the dlngnoatfc vnlua II low. Ths 
pmdlstlvs vnlue QI n normnl echo In tha aldarly pnhant wllh ayncopa mmnms 
to be detsnnlnod 
Fchocnrdiographlc Wall Mollan Abnormality or 
Swum mponln 1 for Pndlctlng Prqnoala In 
Patlants With Unstable Anglna 
A.G. Qlalldoyo, L, Ford, Y.-J. Fang. A.H.B. Wu, CD Glllnm, D. Wntoo. 
C. Chon. tfartlbrd H~gplfflL Univt~~~fy of Connwficuf. Hnrtbrd, C7I USA 
Elavntod sarum Tmponln t (cTnl) pmdlcta poor pmgnosis In pnttonts (phi) 
with unstabta nnglno (UA). Howavar, this obsofvntion hna not boon corrolotod 
to nchac~rdlogrnphlc wnll motlan nbnormnllty (WMA), n mnrkor 01 Intnrctad, 
Ischomlc. stunned or hlbamntln9 myacnnlium. To compare the pmdlctlva 
valuo 01 alovatod cTnl wllh that al WMA tar mo]or cnrdlsc ovonts. wo nnalytod 
lho dnta on 109 consocutlvo pts ndmlttcad with ncuta coronary syndmmo 
(maloa: $596, n)octlon tractton: 44 t Wb). Pts with prlor myocnrdrnl infarction 
(MI) worn oxcludod. Sorum cTnl fovols warn obtalnod nt ndmlsslon whrle 
ochoonrdlogrphy wns porformod wshln 24 hours of admlaston. Of 109 pls. 
47 rulod in for acute MI whrla 62 had a hnnl dlagnasni of UA. Sorum cTnl was 
olovntad In 9 Uh pts (14.5%) whrlo WMA wns present In 39 UA pts (61.3%. 
p . 0.61). All 9 pts (100%) wrth olovntod cTnl had Wfv!A whrle 29 ot 53 pts 
(54.7%) with normnl cTnl hnd WMA. No pl without WMA had olevnled cTnl. 
At 12 I 5 months hollow-up, pts wulth WMA had expenoncod stgn&cnntly moro 
cnrcknc ovonls (mcurront MI. hospilalrralron. rovasculanration. and donth) 
than pts wllhout WMA (31.6O. vs 4.2%. p . 0.01). Tho sonsikvlly. specilictly. 
and positive pmdlctrvo vnluo for cmdlnc ovonts worn 92%. 47%. and 32”. for 
WMA. and 13%. 64%. and 33% for elevated cTnl. 
Conclusions: Echocardiographlc regional WMA appears to bo more sen- 
sitivo than serum cTnt m predicting major cardiac events in pts wnh UA. 
Furthor studies wrth larger number ot pls are nooded lo contirm this hndmg. 
i 1048-l 16 ) Is Mitral Valve Prolapse More Benign In a 
General Fopulatlan? Fwevaluatlon of Echo 
Features In the Framlngham Heart Study 
L.A Frood. E.J. Bonjamm. 0. Levy. M.G. Larson, J.C. Evans, D.L. Fuller, 
B. Lohman. R A. Lovino. Massachuserrs Gsnem/ Hospifaf. Boston. MA: 
NHLBlk Fmmirrghnm Heart Shtdy, Fmmiflgham. MA, USA 
Tho echo leatums of mitral valve pmlapso (MVP) heve been characterized 
m hosprtal.based populations by the frequent occurrence of srgmltcant mitral 
ragurgitalion (MR) and lelt atrial (LA) enlargement. To examine the echo 
features of MVP m en unselected population, we studied all subjects wrth 
possible MVP (n = 151) and 151 age- and sex-matched contmls from ihe 
Framingham Study. Maximal mrtral leallet (ML) superior displacement m 
systole (D) and leaflet thickness rn drastasis (T) were measured. The subtects 
-- 
MVP .sl.dus Clxwc” = 46 Nonclass” = 37 No MVP” = 219 p’ vnlue 
hlL thtcknoss Gmm 4mm 4mm 0.0001 
LA ckanwtor 33 mm 31 mm 30 mm 0 0011 
MR (tot/LA area) to&) 15 1 (muId) 8.7 ,traca, 2 6 (trace) 0.0001 
Antenor ML length 24 mm 22 mm 19mm 0.0001 
PoSterw ML lenglh 15mm 14 null 12mm 0.0001 
‘P-Value compared CIPSSIC + nonClaSslC MVP to no MVP group 
wmo classlllod as classic MVP (D .. 2 m’m. T : 25 mm), nonclasslc MVP (D 
x 2 mm, T _ 5 mm), or no MVP (D ._ 2 mm), and their aasoclated features 
were compared (height- & sex-adjuetod least.squaroa means) (table). 
Conc/us/ons: Although Iho Framlngham MVP aubfecta are slgnlllcantly 
distinct frnm tho no MVP grout? they dlaplay n mom bonlgn form 01 MVP 
than repo,ro? In hoapltal~bassd atudloe. 
1 1048-l 17 Aortlc Supravalvular Dsbrlr Idsntlflud by 
Ranrthornclo Echocardlowa~hy Pmdlctcr 
Carebral Embollc Events - . _ 
V, Knuahtk, C, Ahn, E, Baraach. 7’h@ llniversify crlR%wir MBFI(cRI S&&I (11 
Housfon; kf~rrnrnfl Hor3plfr?l, Hourfan, Ikxils, USA 
Br~ckgrrxmd: Studios dona nl nutnpsy or by tranaesophn~sl or epiaarl~c In, 
tmoporntlvo ochocantlography. Indlcntad that the presence at athemscfemtfo 
plaques In tho aortic nmh Is an lndepandenl tisk lactor al oembraf emboffc 
ovants, Wo faund In a numbsr 01 pationts (pta.) studfed by tranpffroracic 8cfr@ 
onrdrograph~ irmgular amall eshogenia masses in the borl~a root locakrod 
mninly &ova the aartic vslvo. oonsistonl with aotttc athemaclomho debns 
Bnsad on this obrarvntmn. wo sought to nsao%% the pnwalenee ol embokc 
stmkoa in pte. wfth supmvnlvulnr nartic debns. 
rIfefIx% Fmm our acha database we idenklmd. 56 pts. (Qr.1). eve@ 
ffendar dfatnbuted. mean ~ga 67 1 12 ym. on whom aortfo supravafvular 
dabna wore taund on transthoraoto echo. This gmup was compared wflh 56 
pls. (Gr.2) boa at ~ortic dobns. matched lor age. gender and risk tactors 
far ndvnncod nthomsclomsia. Pts. with ntnal kbnllalton or lhmmbus xr the 
omdlac ahnmbers were excluded from the anatysrs. In 69% ol stmks pm.. lha 
ischamfc stmke was dtagnosed by MRt or CT. Chisquare lesis were used Io 
oxamlna the prevaloncfr of ombollc atmkcs belwcon the two groups. 
FlosuL: Tham warn 19 embolic stmkos in Grl (32.6?o) and 5 m Gr.? 
(8 6%)(p . 6.661). On camkd Duplox aonography. no srgmftcant alhemscte. 
rotic chnnaos have boon found in either gmup. 
Conc/usron: 1. Pta. wilh aortlc supravalvular dobns dalected on lranstho- 
rac~c ochocardiogram havo n fourfold mcmase in lhe prevalence of ombotr 
stmkos 2. The pmsonce 01 dobns in the aomc root may explain cerebral 
ombolism and the nood for pmventivo therapy warrants furthor invostrgalron. 
I 1048 118 Predlctlve Value ot lkansthoractc Echocardlography Before Noncardiac Surgery 
I. E. Rohda. C.A. Polancryk. L. Goldman. R.T. Lee. T.H. Lea Brrgham and 
Women’s Hospital. l3oslon. MA. USA 
BactigrounrY Translhoracrc cchocnrdrography (TTE) 1s lroquontty ordered 
belom noncardiac surgery. although 11s value IO predrct ponoperalwe cardrac 
complicalrans IS still contmversral. 
Afofhcxfs~ To ovaluato tho mdcpondcnt prodetwo vatuo 01 TfE. we studrod 
570 pakonls who underwont TTE wrthrn 3 months pnor lo noncardrac surgery. 
Data from dotarted clinical history. phystcal examinalion. olectrocardrographtc 
(ECQ) and laboratory studies were mulmely collected. 
Results: In univariate analysis. any degree 01 preoperakvo syslol~c dys- 
lunckon was associaled wrth postoperative myocardiat infarctron (odds n-1110 
[OR], 2.6 195% Ct. 1.1 to 71). congeslive heart failure (OR. 3.2 (I.4 lo 7)). 
mafor cardiac complications (OR. 2.4 Il.3 to 4.5)) and any cardrac-related 
complications (OR. 2.2 Il.4 lo 3.69 Moderate to severe LV hypertmphy was 
assocrated with myocardral mlarclion (OR. 3.1 Il.1 to 6.31) and with major 
cardiac complications (OR. 2.2 11 ,l to 4.31). In logistic regression analysis. 
models with echocardrographic parameters predicted major cardiac compti- 
catrcns significantly belter than those that included only clinical variables 
(ROC curve 0.66 vs. 0 72; p . 0.001). Even in this selected population, 75% 
of TTE had nonnat LV funclion. Clrnical correlates of a TTE with normal rest- 
ing LV funclion were female gender and the absence of previous myocardial 
infarction. congestive heart failure and 0 waves on the ECG. Among 116 
patients with these charactenstics. 111 (96%) had normal LV lunctron. 
Conclusions: In this populatron. TTE parameters were independent pre- 
dictors of cardiac complications after noncardrac surgery. Simple ciimcal 
features can help to Identify patients with normal LV function and strategies 
should be developed to rdentrfy subsets of patients for whom TTE is an 
appropriate preoperatrve test. 
